FABP4 and ovarian cancer: Inhibition of FABP4 prevented adipocyte-mediated invasion and lipid accumulation in human ovarian cancer cells in vitro, while FABP4 deficiency resulted in fewer metastatic nodules in the ovarian bursa in a mouse model of ovarian cancer [17].